Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization

REFERENCES

• Ambartsumian, N., J. Klingelhofer, M. Grigorian, C. Christensen, M. Kriajevska, E. Tulchinsky, G. Georgiev, V. Berezin, E. Bock, J. Rygaard, R. Cao, Y. Cao, and E. Lukanidin. 2001. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20: 4685–4695.
   PubMed Web of Science ®Google Scholar
• Ambesi-Impiombato, F. S., L. A. Parks, and H. G. Coon. 1980. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc. Natl. Acad. Sci. USA 77: 3455–3459.
   PubMed Web of Science ®Google Scholar
• Andersen, H., S. Mahmood, V. Tkach, M. Cohn, O. Kustikova, M. Grigorian, V. Berezin, E. Bock, E. Lukanidin, and E. Tulchinsky. 2002. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene 21: 4843–4848.
   PubMed Web of Science ®Google Scholar
• Andreasen, P. A., R. Egelund, and H. H. Petersen. 2000. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol. Life Sci. 57: 25–40.
   PubMed Web of Science ®Google Scholar
• Angel, P., A. Szabowski, and M. Schorpp-Kistner. 2001. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20: 2413–2423.
   PubMed Web of Science ®Google Scholar
• Bakiri, L., D. Lallemand, E. Bossy-Wetzel, and M. Yaniv. 2000. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19: 2056–2068.
   PubMedGoogle Scholar
• Bakiri, L., K. Matsuo, M. Wisniewska, E. F. Wagner, and M. Yaniv. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22: 4952–4964.
   PubMedGoogle Scholar
• Battista, S., F. de Nigris, M. Fedele, G. Chiappetta, S. Scala, D. Vallone, G. M. Pierantoni, T. Mega, M. Santoro, G. Viglietto, P. Verde, and A. Fusco. 1998. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene 17: 377–385.
   PubMedGoogle Scholar
• Behrens, A., W. Jochum, M. Sibilia, and E. F. Wagner. 2000. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19: 2657–2663.
   PubMedGoogle Scholar
• Bergers, G., P. Graninger, S. Braselmann, C. Wrighton, and M. Busslinger. 1995. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15: 3748–3758.
   PubMedGoogle Scholar
• Brown, J. R., E. Nigh, R. J. Lee, H. Ye, M. A. Thompson, F. Saudou, R. G. Pestell, and M. E. Greenberg. 1998. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol. 18: 5609–5619.
   PubMedGoogle Scholar
• Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer. 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8: 877–886.
   PubMed Web of Science ®Google Scholar
• Campbell, S. L., R. Khosravi-Far, K. L. Rossman, G. J. Clark, and C. J. Der. 1998. Increasing complexity of Ras signaling. Oncogene 17: 1395–1413.
   PubMed Web of Science ®Google Scholar
• Casamassimi, A., M. G. Miano, A. Porcellini, G. De Vita, F. de Nigris, M. Zannini, R. Di Lauro, T. Russo, V. E. Avvedimento, and A. Fusco. 1998. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation. Cancer Res. 58: 2888–2894.
   PubMed Web of Science ®Google Scholar
• Chiappetta, G., G. Tallini, M. C. De Biasio, F. Pentimalli, F. de Nigris, S. Losito, M. Fedele, S. Battista, P. Verde, M. Santoro, and A. Fusco. 2000. FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin. Cancer Res. 6: 4300–4306.
   PubMed Web of Science ®Google Scholar
• Cobellis, G., C. Missero, and R. Di Lauro. 1998. Concomitant activation of MEK-1 and Rac-1 increases the proliferative potential of thyroid epithelial cells, without affecting their differentiation. Oncogene 17: 2047–2057.
   PubMedGoogle Scholar
• Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol. Cell. Biol. 8: 2063–2069.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., N. Aziz, and M. McMahon. 1999. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19: 330–341.
   PubMed Web of Science ®Google Scholar
• Downward, J. 1996. Control of ras activation. Cancer Surv. 27: 87–100.
   PubMedGoogle Scholar
• Downward, J. 1998. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8: 49–54.
   PubMed Web of Science ®Google Scholar
• Fusco, A., M. T. Berlingieri, P. P. Di Fiore, G. Portella, M. Grieco, and G. Vecchio. 1987. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol. 7: 3365–3370.
   PubMed Web of Science ®Google Scholar
• Gallo, A., A. Feliciello, A. Varrone, R. Cerillo, M. E. Gottesman, and V. E. Avvedimento. 1995. Ki-ras oncogene interferes with the expression of cyclic AMP-dependent promoters. Cell Growth Differ. 6: 91–95.
   PubMedGoogle Scholar
• Gille, H., and J. Downward. 1999. Multiple ras effector pathways contribute to G1 cell cycle progression. J. Biol. Chem. 274: 22033–22040.
   PubMed Web of Science ®Google Scholar
• Gruda, M. C., K. Kovary, R. Metz, and R. Bravo. 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9: 2537–2547.
   PubMed Web of Science ®Google Scholar
• Herdegen, T., and V. Waetzig. 2001. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20: 2424–2437.
   PubMed Web of Science ®Google Scholar
• Hurd, T. W., A. A. Culbert, K. J. Webster, and J. M. Tavare. 2002. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation. Biochem. J. 368: 573–580.
   PubMedGoogle Scholar
• Jochum, W., E. Passegue, and E. F. Wagner. 2001. AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401–2412.
   PubMed Web of Science ®Google Scholar
• Kovary, K., and R. Bravo. 1992. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12: 5015–5023.
   PubMedGoogle Scholar
• Kustikova, O., D. Kramerov, M. Grigorian, V. Berezin, E. Bock, E. Lukanidin, and E. Tulchinsky. 1998. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol. Cell. Biol. 18: 7095–7105.
   PubMed Web of Science ®Google Scholar
• Lloyd, A., N. Yancheva, and B. Wasylyk. 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352: 635–638.
   PubMedGoogle Scholar
• Mechta, F., D. Lallemand, C. M. Pfarr, and M. Yaniv. 1997. Transformation by ras modifies AP1 composition and activity. Oncogene 14: 837–847.
   PubMedGoogle Scholar
• Mechta-Grigoriou, F., D. Gerald, and M. Yaniv. 2001. The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378–2389.
   PubMed Web of Science ®Google Scholar
• Missero, C., M. T. Pirro, and R. Di Lauro. 2000. Multiple ras downstream pathways mediate functional repression of the homeobox gene product TTF-1. Mol. Cell. Biol. 20: 2783–2793.
   PubMedGoogle Scholar
• Murakami, M., M. H. Sonobe, M. Ui, Y. Kabuyama, H. Watanabe, T. Wada, H. Handa, and H. Iba. 1997. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 14: 2435–2444.
   PubMedGoogle Scholar
• Murakami, M., M. Ui, and H. Iba. 1999. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Cell Growth Differ. 10: 333–342.
   PubMedGoogle Scholar
• Murphy, L. O., S. Smith, R. H. Chen, D. C. Fingar, and J. Blenis. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4: 556–564.
   PubMed Web of Science ®Google Scholar
• Musti, A. M., M. Treier, and D. Bohmann. 1997. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400–402.
   PubMed Web of Science ®Google Scholar
• Okazaki, K., and N. Sagata. 1995. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14: 5048–5059.
   PubMed Web of Science ®Google Scholar
• Orlando, V., H. Strutt, and R. Paro. 1997. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11: 205–214.
   PubMed Web of Science ®Google Scholar
• Passegue, E., W. Jochum, M. Schorpp-Kistner, U. Mohle-Steinlein, and E. F. Wagner. 2001. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104: 21–32.
   PubMed Web of Science ®Google Scholar
• Passegue, E., and E. F. Wagner. 2000. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19: 2969–2979.
   PubMed Web of Science ®Google Scholar
• Philips, A., C. Teyssier, F. Galtier, C. Rivier-Covas, J. M. Rey, H. Rochefort, and D. Chalbos. 1998. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol. Endocrinol. 12: 973–985.
   PubMedGoogle Scholar
• Qiu, R. G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374: 457–459.
   PubMed Web of Science ®Google Scholar
• Risse-Hackl, G., J. Adamkiewicz, A. Wimmel, and M. Schuermann. 1998. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene 16: 3057–3068.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89: 457–467.
   PubMed Web of Science ®Google Scholar
• Saez, E., S. E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S. H. Yuspa, and B. M. Spiegelman. 1995. c-fos is required for malignant progression of skin tumors. Cell 82: 721–732.
   PubMed Web of Science ®Google Scholar
• Schreiber, M., A. Kolbus, F. Piu, A. Szabowski, U. Mohle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13: 607–619.
   PubMed Web of Science ®Google Scholar
• Schreiber, M., C. Poirier, A. Franchi, R. Kurzbauer, J. L. Guenet, G. F. Carle, and E. F. Wagner. 1997. Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis). Oncogene 15: 1171–1178.
   PubMedGoogle Scholar
• Schreiber, M., Z. Q. Wang, W. Jochum, I. Fetka, C. Elliott, and E. F. Wagner. 2000. Placental vascularisation requires the AP-1 component fra1. Development 127: 4937–4948.
   PubMedGoogle Scholar
• Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131–E136.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., and M. Karin. 2001. AP-1 in cell proliferation and survival. Oncogene 20: 2390–2400.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., M. Schreiber, F. Piu, M. Beeche, E. F. Wagner, and M. Karin. 2000. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 103: 897–907.
   PubMed Web of Science ®Google Scholar
• Smeal, T., B. Binetruy, D. A. Mercola, M. Birrer, and M. Karin. 1991. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494–496.
   PubMed Web of Science ®Google Scholar
• Suarez, H. G. 1998. Genetic alterations in human epithelial thyroid tumours. Clin. Endocrinol. (Oxford) 48: 531–546.
   PubMedGoogle Scholar
• Treinies, I., H. F. Paterson, S. Hooper, R. Wilson, and C. J. Marshall. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19: 321–329.
   PubMedGoogle Scholar
• Troppmair, J., J. T. Bruder, H. Munoz, P. A. Lloyd, J. Kyriakis, P. Banerjee, J. Avruch, and U. R. Rapp. 1994. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem. 269: 7030–7035.
   PubMedGoogle Scholar
• Vallone, D., S. Battista, G. M. Pierantoni, M. Fedele, L. Casalino, M. Santoro, G. Viglietto, A. Fusco, and P. Verde. 1997. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16: 5310–5321.
   PubMed Web of Science ®Google Scholar
• van Dam, H., and M. Castellazzi. 2001. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20: 2453–2464.
   PubMed Web of Science ®Google Scholar
• Vogt, P. K. 2001. Jun, the oncoprotein. Oncogene 20: 2365–2377.
   PubMedGoogle Scholar
• Weitzman, J. B., L. Fiette, K. Matsuo, and M. Yaniv. 2000. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6: 1109–1119.
   PubMedGoogle Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., R. S. Johnson, and C. Moore. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18: 188–197.
   PubMed Web of Science ®Google Scholar
• Young, M. R., J. J. Li, M. Rincon, R. A. Flavell, B. K. Sathyanarayana, R. Hunziker, and N. Colburn. 1999. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA 96: 9827–9832.
   PubMed Web of Science ®Google Scholar
• Young, M. R., R. Nair, N. Bucheimer, P. Tulsian, N. Brown, C. Chapp, T. C. Hsu, and N. H. Colburn. 2002. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol. 22: 587–598.
   PubMed Web of Science ®Google Scholar
• Zuber, J., O. I. Tchernitsa, B. Hinzmann, A. C. Schmitz, M. Grips, M. Hellriegel, C. Sers, A. Rosenthal, and R. Schafer. 2000. A genome-wide survey of RAS transformation targets. Nat. Genet. 24: 144–152.
   PubMed Web of Science ®Google Scholar